Apollo Hospitals Enterprise Limited

What does Apollo Hospitals own?
Apollo Hospitals operates 78 hospitals with 10,970 beds, 7,289 Apollo Pharmacy stores, 2,501 Apollo Diagnostics centers, 280 Apollo Dental centers, 167 Apollo Dialysis centers, 316 Apollo Clinics, and the Apollo 24/7 digital health platform. The company operates through three main subsidiaries: Apollo HealthCo (pharmacy and digital health), Apollo Health and Lifestyle (diagnostics and clinics), and the core Healthcare Services division (hospitals).

Is Apollo Hospitals publicly traded?
Yes, Apollo Hospitals is listed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) under the ticker symbol APOLLOHOSP. Promoter shareholding is 28.02% as of March 31, 2026, with the remainder held by institutional investors, mutual funds, and retail shareholders.

Who founded Apollo Hospitals?
Dr. Prathap C. Reddy, a cardiologist, founded Apollo Hospitals in 1983. He established India's first corporate hospital in Chennai, pioneering corporate healthcare delivery in the country. Dr. Reddy continues to serve as Chairman of the company.

What is Apollo Hospitals' revenue?
Apollo Hospitals reported FY2026 consolidated revenue of Rs 25,229 crore, up 16% year on year. Consolidated EBITDA was Rs 3,769 crore (25% YoY growth), and consolidated PAT was Rs 1,942 crore (34% YoY growth). This was the first time the company's revenue crossed Rs 25,000 crore.

How many hospitals does Apollo have?
Apollo operates 78 hospitals with a total capacity of 10,970 beds across India and overseas. Of these, 9,481 beds are in 49 owned hospitals, 699 beds are in day surgery and cradle facilities, and 790 beds are in 6 managed hospitals. The company plans to add 3,415 beds across India, with 1,500 beds expected in the next 12 to 18 months.

Who owns Apollo Hospitals?
Apollo Hospitals is publicly traded with promoter shareholding of 28.02% as of March 31, 2026. The promoters are the Reddy family and related entities. The remaining shares are held by institutional investors, mutual funds, foreign portfolio investors, and retail shareholders through NSE and BSE trading.

Where is Apollo Hospitals headquartered?
Apollo Hospitals is headquartered in Chennai, Tamil Nadu, India. The company has major hospital operations across Indian cities including Delhi, Mumbai, Bangalore, Hyderabad, Kolkata, and Pune, as well as international locations.

What is the Apollo 24/7 platform?
Apollo 24/7 is the company's digital health platform with 47 million registered users and 9 lakh daily active users. It offers teleconsultation, medicine delivery, and diagnostic booking. The platform recorded a gross merchandise value (GMV) of Rs 2,037 crore in FY2026. Apollo 24/7 incurred costs of Rs 467 crore during FY2026 as the company continues to invest in building the digital healthcare ecosystem.

Dr. Prathap C. Reddy, a cardiologist trained in the United States, founded Apollo Hospitals in 1983. He opened India's first corporate hospital, a 150-bed facility in Chennai, with the goal of providing world-class healthcare in India so that patients would not need to travel abroad for treatment. The hospital introduced modern healthcare infrastructure and practices that were not previously available in the country.

Throughout the 1980s and 1990s, Apollo expanded to major Indian cities including Delhi, Mumbai, Bangalore, and Hyderabad. The company invested in advanced medical technology and specialized departments, establishing itself as a leader in India's emerging private healthcare sector. Apollo went public on Indian stock exchanges, giving it access to capital for expansion.

In the 2000s, Apollo expanded internationally with hospitals and healthcare operations in countries including Bangladesh, Sri Lanka, and the Gulf states. The company also diversified beyond hospital operations, launching Apollo Pharmacy as a retail pharmacy chain, Apollo Diagnostics for laboratory services, and Apollo Telehealth for remote consultations.

In the 2010s and 2020s, Apollo continued to build its integrated healthcare ecosystem. The company launched Apollo 24/7, a digital health platform that now has 47 million registered users and 9 lakh daily active users. Apollo Health and Lifestyle expanded into fertility, dental, and dialysis services through specialized clinic formats.

In FY2026, Apollo operationalized four new hospitals: Apollo Athenaa in NCR, Pune, Financial District in Hyderabad, and Narendrapur in Kolkata, with a combined potential capacity of 855 beds. The company plans to commission two more hospitals in Sarjapur and Gurgaon in the next two quarters, adding approximately 1,400 operating beds in key metro markets. Apollo also announced a planned demerger of its pharmacy and digital health businesses into a separate entity, with a potential listing by Q4 FY27.

Apollo Hospitals has implemented ESG initiatives across its hospital network, focusing on environmental responsibility, healthcare accessibility, and medical ethics. The company participates in the Climate Learning Initiative and has implemented data-backed platforms to capture and manage environmental performance metrics across its operations.

Environmental sustainability initiatives include energy-efficient hospital design, renewable energy adoption, waste management programs, and water conservation measures. Apollo has implemented green building standards for new facilities and medical waste recycling programs. The company aims to achieve carbon neutrality across its hospital network by 2040.

Healthcare accessibility programs address disparities in India's healthcare system. Apollo's CSR spending reached Rs 20.83 crore for FY2025, supporting initiatives that improve healthcare access for disadvantaged populations. The company operates charitable clinics, free health camps, and community outreach programs serving underserved populations.

Medical ethics and patient safety form the foundation of Apollo's clinical operations. The company maintains comprehensive clinical governance programs, quality control systems, and patient safety protocols. Apollo participates in national healthcare accreditation programs through the National Accreditation Board for Hospitals (NABH) and international accreditation through Joint Commission International (JCI).

• NABH Accreditation: Multiple Apollo hospitals hold National Accreditation Board for Hospitals accreditation, the gold standard for healthcare quality in India
• JCI Accreditation: Select Apollo hospitals hold Joint Commission International accreditation, recognized globally as a mark of healthcare quality
• Healthcare Excellence Awards: Recognition for clinical quality, patient safety, and healthcare service delivery across medical specialties
• Digital Health Innovation: Awards for telemedicine implementation and digital healthcare transformation through Apollo 24/7
• Medical Tourism Excellence: Recognition as a leading destination for medical tourism in India
• CSR Leadership: Recognition for corporate social responsibility initiatives and community healthcare programs

Medical negligence cases have drawn regulatory attention and public criticism. In March 2024, the National Consumer Disputes Redressal Commission fined Apollo Speciality Hospital in Chennai and two doctors Rs 30 lakh for medical negligence involving a patient who remained in a vegetative state after spinal surgery in April 2015. The case raised concerns about medical accountability and patient safety protocols in private hospitals.

Ethical concerns have been raised regarding doctor referrals and diagnostic procedures, including questions about kickbacks to doctors for expensive diagnostic procedures like CT scans. These practices have drawn scrutiny from medical councils regarding conflicts of interest and unnecessary medical procedures in the private healthcare sector.

Healthcare pricing and affordability are ongoing issues. Apollo, as a premium healthcare provider, faces questions about pricing transparency, treatment costs, and accessibility for middle and lower-income patients. The cost of private healthcare in India has attracted attention from consumer advocacy groups and healthcare regulators.

Regulatory compliance is complex. Apollo must navigate oversight from the National Medical Commission (formerly Medical Council of India), NABH, various state healthcare authorities, and the Drug Controller General of India for its pharmacy operations. The company must maintain medical licensing, facility standards, and clinical quality across its extensive network.

Apollo's expansion plans have raised questions about market concentration. The company's plan to add 3,415 beds across India has drawn scrutiny regarding market dominance in certain regional healthcare markets and the impact on healthcare accessibility and pricing.

Data privacy and security are growing concerns. Apollo handles sensitive medical information through its hospitals, pharmacy network, and Apollo 24/7 digital platform. The company must comply with healthcare data protection regulations and patient confidentiality requirements under evolving Indian privacy laws.